The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of treatment sequence in metastatic castration-resistant prostate cancer (mCRPC) on outcome in a prospective cohort study.
 
Rebeca Lozano
Speakers' Bureau - Janssen-Cilag; Roche
Travel, Accommodations, Expenses - Janssen-Cilag; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag
Consulting or Advisory Role - Bayer; Bayer (I); Janssen; Janssen (I)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche
 
Ana Medina
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi
Other Relationship - Novartis
 
Jose Carlos Villa Guzman
No Relationships to Disclose
 
Iciar Garcia Carbonero
No Relationships to Disclose
 
Rosa Villatoro
No Relationships to Disclose
 
Jose Angel Arranz
Honoraria - Astellas Medivation; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Medivation; Bristol-Myers Squibb; Janssen
 
Jose Luis Perez-Gracia
No Relationships to Disclose
 
Javier Garde
No Relationships to Disclose
 
Aranzazu Gonzalez del Alba
Honoraria - Astellas Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; PFIZER; Sanofi
 
A. Montesa
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Pfizer
 
Raquel Luque
No Relationships to Disclose
 
Pablo Borrega
No Relationships to Disclose
 
Sergio Vázquez
Consulting or Advisory Role - Astellas Medivation; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Medivation; Bayer
Travel, Accommodations, Expenses - Astellas Medivation; Bayer; Janssen
 
Esther Martinez
No Relationships to Disclose
 
Belen Gonzalez Gragera
No Relationships to Disclose
 
Nuria Romero-Laorden
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; Pfizer; PharmaMar; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Pfizer; Roche
 
David Olmos
Honoraria - Bayer; Janssen; Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Janssen
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen
 
David Lorente
Consulting or Advisory Role - Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Medivation; Bayer; Janssen; Sanofi
Travel, Accommodations, Expenses - Astellas Medivation; Celgene; Janssen; Sanofi